DalsnaFinance › IPOs › Recursion Pharmaceuticals Inc Clas › IPO

RECURSION PHARMACEUTICALS, INC. IPO

Completed

RECURSION PHARMACEUTICALS, INC. completed its initial public offering on NASDAQ on April 16, 2021, pricing at $18.00 a share.

Ticker	RXRX
Exchange	NASDAQ
Status	Completed
Listing date	April 16, 2021
Offering price	$18.00
Shares offered	24,242,424
Total raised	$436M

The offering

RECURSION PHARMACEUTICALS, INC. sold 24,242,424 shares at $18.00 each on NASDAQ. Multiplied out, that is $436.4 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $436 million total recorded for the deal.

Company coverage

RECURSION PHARMACEUTICALS, INC. — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for RECURSION PHARMACEUTICALS, INC.. This page is general information, not investment advice.